ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 58 for:    essential oils

Essential Oils on Anxiety of Patients Suffering From Cancer (RHECAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02835352
Recruitment Status : Terminated (Too slow recruitment and study data to be recorded not available.)
First Posted : July 18, 2016
Last Update Posted : January 24, 2018
Sponsor:
Information provided by (Responsible Party):
Center Eugene Marquis

Brief Summary:
This study evaluates the impact of essential oils massage on anxiety of patients who are suffering from cancer at a metastasis stage. Half of patients will be massaged first by essential oils and then by oil only. The other half will be massaged first by oil and then by essential oils.

Condition or disease Intervention/treatment Phase
Neoplasm Metastasis Other: Essential oils massages Other: Oil massages Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 29 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Impact of Essential Oils on Anxiety of Patients Suffering From Metastasis Cancer - Feasibility Study
Actual Study Start Date : June 21, 2016
Actual Primary Completion Date : May 1, 2017
Actual Study Completion Date : May 1, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: Essential oils then oil massages
Essential oils massages will be done as needed during a period of 7 days, then oïl massages as needed will be done during a follow-up period of 7 days
Other: Essential oils massages
Other: Oil massages
Experimental: Oil then essential oils massages
Oil massages will be done as needed during a period of 7 days, then essential oïl massages as needed will be done during a follow-up period of 7 days
Other: Essential oils massages
Other: Oil massages



Primary Outcome Measures :
  1. Anxiolytic consumption [ Time Frame: 7 days ]
    Anxiolytic consumption will be assessed at day 7 at the end of each phase



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult suffering from cancer at a metastatic stage
  • Life expectancy > 15 days, assessed by investigator
  • Hospitalized at the Chevrel unit from Centre Eugène Marquis, palliative unit care, for more than 15 days
  • Regular anxiolytic treatment or imperative need to introduce anxiolytic treatment (assessed by investigator) within 48 hours following his hospitalization entry
  • > 18 years

Exclusion Criteria:

  • Patient already recruited in a therapeutic trial
  • Patient not covered by a social security system
  • Pregnant or likely pregnant patient, breastfeeding patient
  • Allergy to any component of essential oils mixture and vegetable oils : bitter orange petitgrain, fine lavender, ylang-ylang, macadamia
  • Minors, people deprived of their liberty or protected people,
  • Impaired cognitive functions making impossible to obtain informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02835352


Locations
France
Centre Eugène Marquis
Rennes, France
Sponsors and Collaborators
Center Eugene Marquis
Investigators
Principal Investigator: Agnès Hutin, MD Centre Eugène Marquis

Responsible Party: Center Eugene Marquis
ClinicalTrials.gov Identifier: NCT02835352     History of Changes
Other Study ID Numbers: 2014-AH-DOUL-SC
First Posted: July 18, 2016    Key Record Dates
Last Update Posted: January 24, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Not authorized by French law

Keywords provided by Center Eugene Marquis:
anxiety

Additional relevant MeSH terms:
Neoplasm Metastasis
Neoplastic Processes
Neoplasms
Pathologic Processes